• Main
• About us
• Cooperation
• To Specialists
• Products
• News
• Contacts

Products

Anaferon

Anaferon belongs to the group of immunomodulators and antiviral agents. The drug exerts dual action, that is, early antiviral action mediated through the induction of IFN-α and complementary antiviral аnd full-scale immunomodulatory effects that are realized via IFN-γ production.

All Products

News

On June 16-18th “Men’s health” 6th All-Russian Congress took place in Moscow in building of Russian Federation Academy of Science. “Materia Medica Holding” traditionally took part in the congress.

On May 30th “Materia Medica” organized cheerful occasion timed to International Children Defence Day. The occasion took place in major children toy store “Skazka”.

Epidemic situation 2009 clearly showed the necessity to search for new effective domestic antiviral remedies to cure flu. Ministry for Healthcare ordered strict experimental researches of different antiviral products in two leading scientific-research institutes. The goal of the research is to clear up which Russian medicines are as effective as those recommended by WHO.

Marketing authorization for Impaza, was issued by “State Institute for Drug Control”, Slovakia. This is the first drug produced by Materia Medica Holding to be registered in EU.

Federal service for healthcare supervision and social development has proven Materia Medica Holding organization of medicinal products production and quality control meet the requirements of GMP standards resulting from last inspection.

Anaferon is included in final the TOP-4 in nomination for “OTC medicinal product”

Materia Medica Holding will participate in annual Russian National Congress “Man and Remedy”

Anaferon is one of the leader of sales volume in commercial retail sector

Roszdravnadzor (HealthCare Ministry) has registered the price for Anaferon for children in the list of vitally important medicines...

USA patent department has issued patent for unique composition which is the base for Impaza...